Non-Alcoholic Fatty Liver Disease (NAFLD) Reversal: Emerging Strategies for Liver Health

Abstract

Non-alcoholic fatty liver disease (NAFLD), currently one of the most prevalent types of chronic liver disease, affects over 25% of adults and a growing percentage of children worldwide. Obesity, insulin resistance, and metabolic syndrome are intimately linked to NAFLD, which covers basic steatosis from more severe disorders including Nonalcoholic Steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Although NAFLD has long been seen to be a chronic and irreversible syndrome, in its early stages, particularly before the development of significant fibrosis or cirrhosis, it can be reversible through interventions like weight loss and improved lifestyle.Dietary changes, exercise, weight loss, and pharmaceutical advancements in some suspected etiology cases should all be successful tactics. Without behavioral and psychological support in addition to medical management, long-term changes cannot be maintained. The prevalence of NAFLD globally, its underlying causes, and several reversal methods are examined in this article along with the difficulties and possible future paths in liver health treatment.

Keywords: Metabolic Syndrome, Fatty Liver Disease Reversal, Non-Alcoholic Steatohepatitis, Liver Health, Lifestyle Changes, Medication